Benefit of ICD attenuated in CKD patients receiving cardiac resynchronization

by

For patients with advanced chronic kidney disease (CKD) receiving cardiac resynchronization therapy (CRT), the benefit of an implantable cardioverter defibrillator (ICD) may be attenuated, according to a study published online Aug. 23 in Frontiers in Cardiovascular Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *